Nickolai Dulin, Ph.D.
Signaling Mechansisms by G Protein Coupled Receptors
(GPCR)
Research Summary
My laboratory studies the mechanisms of G
protein-mediated signal transduction, as they relate to gene
expression, cell growth and survival. We focus on the signaling induced
by the vasoactive agonists, such as endothelin-1 (ET1) and
extracellular ATP, which are relevant to cardiovascular, pulmonary and
renal physiology. The goal is to dissect the role of various
heterotrimeric G proteins, small GTPases and protein kinases in
activation of gene transcription by ET1 or ATP in vascular smooth
muscle cells. Serum response factor (SRF) – a transcription factor that
controls expression of smooth muscle-specific proteins – is of
particular interest to our lab. The complex mechanism of SRF regulation
and smooth muscle gene expression by ET1 and ATP is an important part
of these studies.
Regulators of G protein Signaling (RGS) – is another, yet closely
related, focus of our laboratory. The established function of RGS
proteins is to bind and inactivate the alpha subunits of heterotrimeric
G proteins. However, increasing evidence suggests that this is not the
only function of RGS proteins, as they can bind other targets. We
have found that one of the RGS family members, RGS3, can interact with
the phosphoserine-binding protein 14-3-3, which regulates many
signaling molecules implicated in cell growth and survival. A
long isoform of RGS3, PDZ-RGS3, can interact with Ephrin B – a
transmembrane ligand for the ephrin B receptors implicated in cell-cell
communication. Another splice variant of RGS3, SRB-RGS, binds
steroid receptors, such as estrogen receptors. Elucidation of the
new functions of RGS3 isoforms is the goal of this study.
Selected Papers
Dulin NO, Alexander LD, Harwalkar S, Falk JR and Douglas
JG. (1998). Phospholipase A2-mediated activation of mitogen-activated
protein
kinase by angiotensin II. Proc. Natl. Acad. Sci. USA. 95:8098-8102.
Dulin NO, Sorokin A and Douglas JG. (1998).
Arachidonate-induced
tyrosine phosphorylation of epidermal growth factor receptor and
Shc-Grb2-Sos association. Hypertension 32:1089-1093.
Dulin NO, Sorokin A, Reed E, Elliott S, Kehrl GH, and
Dunn MJ. (1999). RGS3 inhibits G protein-mediated signaling via
translocation
to the membrane and binding to Ga11. Mol. Cell. Biol. 19:714-723.
Dulin NO, Pratt P, Voyno-Yasenetskaya T and Dunn MJ.
(2000). Regulator of G protein signaling RGS3T is localized to the
nucleus and
induces apoptosis. J. Biol. Chem. 275:21317-21323.
Dulin NO, Niu J, Browning DD, Ye R and
Voyno-Yasenetskaya T. (2001). Cyclic AMP - independent activation of
protein
kinase A by vasoactive peptides. J. Biol. Chem. 276:20827-20830.
Dulin NO, Orlov SN, Kitchen CM, Voyno-Yasenetskaya T and
Miano J. (2001). G-protein-coupled-receptor activation of the smooth
muscle
calponin gene. Biochem. J. 357:587-592.
Niu J, Scheschonka A, Druey K, Davis A, Reed E, Kolenko
V, Bodnar R, Voyno-Yasenetskaya T, Du W, Kehrl J and Dulin NO. (2002).
RGS3
interacts with 14-3-3 via the N-terminal region distinct from RGS
domain. Biochem. J. 365: 677-684.
Davis A, Hogarth K, Fernandes D, Solway J, Niu J,
Kolenko V, Browning D, Miano JM, Orlov SN, Dulin NO. (2003). Functional
significance of protein kinase A activation by endothelin-1 and ATP:
negative regulation of SRF-dependent gene expression by PKA. Cell.
Signal. 15:597-604.
Hogarth DK, Sandbo N, Taurin S, Kolenko V, Miano JM, and
Dulin NO. (2004). Dual role of PKA in the phenotypic modulation of
vascular smooth muscle cells by extracellular ATP. Am. J. Phys. Cell
Physiol. 287:C449-C456.
Sandbo N, Qin Y, Taurin S, Hogarth DK, Kreutz B, Dulin
NO. (2005). Regulation of SRF-dependent gene expression by proteasome
inhibitors. Mol. Pharmacol. 67:789-797.
Taurin S, Sandbo N, Qin Y, Browning D, and Dulin NO.
(2006). Phosphorylation of beta-catenin by cyclic AMP-dependent protein
kinase. J. Biol. Chem. 281(15):9971-9976.
|